Friday, May 6, 2011

Medivation halves Q1 loss

Drug company Medivation Inc. cut its Q1 loss in half to $8.5 million.
A year earlier the San Francisco company (NASDAQ: MDVN) lost $17.5 million.
Revenue was about flat -- $14.7 million in the March quarter compared with $15.7 million a year earlier.

No comments:

Post a Comment